CVS Group publishes investor presentation on capital allocation and returns

• CVS outlined FY2026 unaudited headlines with revenue up 5.9% to GBP 712.8 million, adjusted EBITDA at about GBP 141.5 million.
• Like-for-like revenue rose 2.1% with adjusted EBITDA margin around 20%; net debt at June 30 was GBP 199.6 million, leverage 1.63x.
• Capital allocation framework centered on progressive ordinary dividends, about GBP 30 million a year of investment capex, about GBP 50 million a year for acquisitions.
• Balance sheet guardrail set at below 2x leverage, with scope to temporarily exceed 2.0x for larger acquisitions.
• Free cash flow described at about GBP 70 million, with about GBP 10 million earmarked for contingent deferred consideration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Group plc published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.